India's largest enzyme and probiotics manufacturer, serving human nutrition, animal nutrition and industrial bio-processing clients worldwide.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 |
| Reserves | 348 | 413 | 458 | 503 | 558 | 607 | 1.5k | 687 |
| Borrowings | 10 | 1 | 2 | 2 | 2 | 3 | 35 | 2 |
| Other Liabilities | 42 | 53 | 48 | 48 | 51 | 57 | 173 | 92 |
| Total Liabilities | 423 | 489 | 530 | 576 | 633 | 689 | 1.7k | 804 |
| AssetsFixed Assets | 127 | 131 | 132 | 143 | 142 | 156 | 683 | 151 |
| CWIP | 10 | 7 | 9 | 11 | 22 | 21 | 31 | 49 |
| Investments | 121 | 184 | 189 | 201 | 256 | 290 | 529 | 345 |
| Other Assets | 165 | 166 | 200 | 220 | 213 | 221 | 449 | 259 |
| Total Assets | 423 | 489 | 530 | 576 | 633 | 689 | 1.7k | 804 |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 35 | 46 | 84 | 37 | 50 | 52 | 63 | 89 |
| Cash from Investing | -2 | -25 | -70 | -14 | -42 | -3 | -2 | -34 |
| Cash from Financing | -33 | -19 | -15 | -11 | -12 | -57 | -58 | -58 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 32 | 5 | 75 | 28 | 27 | 31 | 41 | 44 |
| FCF Margin | — | — | — | — | — | — | — | — |
This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.
ADVENZYMES · CYCLICAL_UNMODELABLE
Guides on how to read this kind of business and the numbers that matter.